Delta-Fly Pharma Inc.: Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 combined with Venetoclax
Delta-Fly: FDA submission of the protocol of the Phase I/II study of DFP-10917
Delta-Fly Pharma: Abstracts submission for Phase I Clinical Trial of DFP-14927
Delta-Fly Pharma Inc.: Notice of Initiation of PIII Pivotal trial of DFP-14323
Delta-Fly Pharma: Update on the R&D status of DFP-10917 and DFP-14927